4//SEC Filing
O'Brien Stephen Paul 4
Accession 0001415889-25-011117
CIK 0001346830other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:15 PM ET
Size
5.8 KB
Accession
0001415889-25-011117
Insider Transaction Report
Form 4
O'Brien Stephen Paul
Principal Accounting Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-04-17+7,213→ 7,213 totalExercise: $17.04Exp: 2035-04-16→ Common Stock (7,213 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Tvardi Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0002064889
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:15 PM ET
- Size
- 5.8 KB